Paxman Scalp Cooling is available in Hong Kong and Macau through WKK Medical Equipment Co Ltd.

Paxman 頭皮冷涷在 香港和澳门 由 WKK Medical Equipment Co Ltd. 提供。


Scalp cooling is increasingly considered a standard of care within chemotherapy treatment, as prioritising side-effect management and improving a patient's experience of treatment is being prioritised in cancer care.


The trauma of hair loss does not have to be inevitable if scalp cooling is offered by your centre.


Chemotherapy-induced alopecia is universally considered to be one of the most feared side-effects of treatment, with up to 10% of patients either refusing chemotherapy or choosing a less effective regimen to avoid hair loss.1,2

Our systems lead the way in scalp cooling technology, providing easy-to-use, efficacious solutions for clinicians and their patients.

Paxman have over 20 years of experience of implementing scalp cooling systems across the world, and can provide the expertise needed to integrate scalp cooling seamlessly into your clinical practice.


普遍認為化療引起的脫髮是治療中最可怕的副作用之一,大約 8% 的患者因而拒絕接受化療或選擇功效稍遜的治療方法來避免脫髮。1,2


Paxman 在全球使用頭皮冷凍系統方面擁有 20 多年經驗,可以提供將頭皮冷凍無縫整合至臨床實踐中所需的專業知識。

More on Paxman / 了解更多

Scalp cooling use continues to increase as patients are becoming more aware of the possibility of hair retention and the long-term benefits of hair follicle protection that leads to faster hair regrowth.


Chemotherapy-induced alopecia can be traumatic, with over 75% of patients citing it was the most feared side effect of their treatment. Chemo hair loss can:3

  • Lead to social isolation
  • Have a negative effect on patient’s self-image, more so than breast surgery
  • Remove a patient’s privacy and feeling of a normal life


化療引起的脫髮可能是一種創傷,超過 75% 的患者認為這是治療中最可怕的副作用。化療引起的脫髮可以; 3

  • 導致社交孤立
  • 對患者的自我形象產生負面影響,比乳房手術更嚴重
  • 奪走患者的私隱和正常生活的感覺

Summary of published scalp cooling data / 已發表的頭皮冷凍數據摘要

Study Subjects / 多名研究受試者
Abstracts & Publications / 份摘要與刊物
Clinical Trials / 項臨床試驗
Overall Success Rate / 整體成功率

Cooled: 10-100% / Non-Cooled: 0-26%
冷凍 = 10-100% / 非冷凍 = 0-26%

Efficacy rates for patient hair retention / 保留患者頭髮的有效率

Anthracyclines / 蒽環類藥物
Taxane-based regimens / 紫杉醇類治療方案
Main efficacy variances in results / 結果的主要功效差異:

- Relate to the type and dosage of chemotherapy
- Experience in using scalp cooling


- 與化療的類型和劑量相關

- 使用頭皮冷凍的經驗

Paxman Patient Support / Paxman 患者支援

Paxman pride themselves on going above and beyond when supporting patients, providing advice and guidance through every step of the process. From informed decision making at the point of diagnosis, and tutorial videos to ensure the best possible cap fit as well as hair care advice.

We know that an informed patient has a better outcome, which is why education and support is our priority. Visit our patient site coldcap.com for more information.


Paxman 很自豪能在頭皮冷凍過程的每一步為患者提供卓越的支援、建議和指導。從根據藥物類型的功效資料在診斷後作出明智的決策,逐步指導影片可幫助確保帽子達到最佳的貼合度,以及度身訂做的護髮建議。

我們深明知情的患者會有更好的結果,因此,教育和支援是我們的首要任務。瀏覽我們的患者網站 coldcap.com 了解更多資訊。


If you want to get in touch with WKK Medical Equipment Co Ltd. see below / 如要聯絡 WKK Medical Equipment Co Ltd.,詳情如下:

WKK Medical Equipment Co Ltd.

17/F Octa Tower
No.8 Lam Chak Street
Kowloon Bay
Hong Kong

Phone: 852 2357-8055
Fax: 852 2341-9339
E-Mail: Chris_Chan@wkk.com.hk


1 Kdakia et al. Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage. 2014;47:1100-1115.

2 Roe H. Scalp cooling: management option for chemotherapy-induced alopecia. Br J Nurs. 2014;23(suppl):S4-S12.

3 Kargar et al. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. J Advanced Nurs. 2011;67(11):2473-2477. / Roe H. Chemotherapy-induced alopecia: advice and support for hair loss. Br J Nurs. 2011.20 (suppl):S4-S11. / Ross M, Fischer-Cartlidge E. Scalp cooling: a literature review of efficacy, safety, and tolerability for chemotherapy-induced alopecia. CJON. 2017;21(2):226-233. / Kdakia KC et al. Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage. 2014;47:1100-1115. / Roe H. Scalp cooling: management option for chemotherapy-induced alopecia. Br J Nurs. 2014;23(suppl):S4-S12.

© Paxman Coolers 2022